PHAXIAM THERAPEUTICS S.A. Zu einer Liste hinzufügen
|
Schlusskurs
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
| 1.682 EUR | -0.36% |
|
+0.12% | -63.43% |
| 12.06. | Phaxiam: Kapitalerhöhung um zehn Millionen Euro | CF |
| 15.04. | Phaxiam: Beginn der Studie zur infektiösen Endokarditis | CF |
Hauptkonkurrenten
Zu einer Liste hinzufügen 0 ausgewählt | % | % 5 Tage | Veränderung - 1 Monat | Veränderung - 3 Monate | % 1. Jan. | % 1 Jahr | Veränd. 3 J. | Veränd. 5 J. | Veränd. 10 J. | Kap. ($) | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.36% | +0.12% | -9.08% | -41.50% | -63.43% | -60.79% | -96.78% | -96.60% | -98.93% | 18.22 Mio. | ||
| +0.45% | -3.22% | +0.90% | +12.95% | +29.96% | +36.94% | +75.48% | +302.87% | +225.81% | 123 Mrd. | ||
| +0.84% | -0.80% | +1.34% | -1.41% | +16.68% | +36.73% | +151.76% | +174.24% | +403.70% | 123 Mrd. | ||
| +0.74% | +4.75% | +1.03% | +39.84% | +43.17% | +0.02% | +76.27% | +340.68% | +5’890.26% | 32.38 Mrd. | ||
| -1.35% | +11.51% | +22.86% | +0.48% | -5.94% | -15.84% | -71.57% | - | - | 23.6 Mrd. | ||
| +6.80% | +11.93% | +15.53% | +33.14% | +17.07% | +0.91% | -40.01% | +64.86% | - | 22.43 Mrd. | ||
| -2.37% | -3.08% | +0.22% | -4.49% | -16.06% | -30.21% | -35.00% | +34.05% | +679.07% | 16.95 Mrd. | ||
| -1.18% | +89.17% | +110.58% | +201.06% | +769.73% | +1’292.64% | +249.23% | +1’550.91% | - | 16.45 Mrd. | ||
| +3.35% | -2.18% | -7.13% | -9.23% | -47.03% | -50.27% | -72.63% | -19.92% | - | 15.37 Mrd. | ||
| -2.31% | +4.03% | +45.78% | +56.45% | +80.81% | +116.62% | +334.06% | - | - | 14.05 Mrd. | ||
| +1.66% | -3.31% | -1.65% | +17.60% | +134.79% | +174.57% | +167.99% | +278.76% | +429.16% | 12.5 Mrd. | ||
| +1.14% | -4.75% | +2.43% | +5.78% | +33.14% | +8.44% | +59.55% | +44.13% | +440.13% | 12.24 Mrd. | ||
| +1.99% | -0.87% | -17.55% | -8.77% | -7.81% | +10.79% | +25.56% | +27.31% | +641.12% | 12.27 Mrd. | ||
| -0.10% | -13.31% | -11.00% | +12.43% | -17.32% | -29.04% | +33.06% | - | - | 9.11 Mrd. | ||
| +4.98% | +5.35% | +0.67% | +38.41% | +139.95% | +221.89% | +338.11% | +460.04% | +1’152.45% | 9.38 Mrd. | ||
| +0.74% | -.--% | -.--% | +11.62% | +6.04% | +87.02% | +22.17% | - | - | 8.19 Mrd. | ||
| +0.22% | -4.41% | +7.59% | +18.97% | +60.69% | +58.37% | +44.01% | +259.50% | +528.47% | 7.52 Mrd. | ||
| +1.22% | +3.98% | -1.26% | +20.88% | +11.00% | +21.10% | +33.42% | +37.20% | +1’294.24% | 7.6 Mrd. | ||
| +0.15% | +2.24% | -0.44% | +42.41% | +97.98% | +88.71% | +620.29% | +487.98% | +340.54% | 7.04 Mrd. | ||
| -1.59% | -5.50% | -11.06% | -14.40% | -10.34% | +12.86% | -26.88% | +7.26% | - | 6.48 Mrd. | ||
| Durchschnitt | +0.70% | +4.52% | +7.49% | +21.61% | +63.65% | +99.07% | +94.41% | +247.08% | +993.84% | 23.97 Mrd. | |
| Gewichteter Durchschnitt nach Marktkapitalisierung | +0.52% | +2.96% | +6.73% | +17.96% | +51.19% | +76.29% | +96.87% | +262.32% | +894.17% |
- Börse
- Aktien
- A3EJH8 Aktie
- Sektor PHAXIAM Therapeutics S.A.
MarketScreener is also available in this country: United States.
Switch edition
Bei der aktuellen länderspezifischen Edition bleiben